Junzo Nojima
Laboratory for Clinical Investigation
Osaka University Hospital
Suita
Osaka 565-0871
Japan
Name/email consistency: high
- Tissue factor expression on monocytes induced by anti-phospholipid antibodies as a strong risk factor for thromboembolic complications in SLE patients. Nojima, J., Masuda, Y., Iwatani, Y., Suehisa, E., Futsukaichi, Y., Kuratsune, H., Watanabe, Y., Takano, T., Hidaka, Y., Kanakura, Y. Biochem. Biophys. Res. Commun. (2008)
- Arteriosclerosis obliterans associated with anti-cardiolipin antibody/beta2-glycoprotein I antibodies as a strong risk factor for ischaemic heart disease in patients with systemic lupus erythematosus. Nojima, J., Masuda, Y., Iwatani, Y., Kuratsune, H., Watanabe, Y., Suehisa, E., Takano, T., Hidaka, Y., Kanakura, Y. Rheumatology. (Oxford) (2008)
- Strong correlation between the prevalence of cerebral infarction and the presence of anti-cardiolipin/beta2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies--Co-existence of these antibodies enhances ADP-induced platelet activation in vitro. Nojima, J., Kuratsune, H., Suehisa, E., Kitani, T., Iwatani, Y., Kanakura, Y. Thromb. Haemost. (2004)
- Acquired activated protein C resistance is associated with the co-existence of anti-prothrombin antibodies and lupus anticoagulant activity in patients with systemic lupus erythematosus. Nojima, J., Kuratsune, H., Suehisa, E., Kawasaki, T., Machii, T., Kitani, T., Iwatani, Y., Kanakura, Y. Br. J. Haematol. (2002)
- Acquired activated protein C resistance associated with anti-protein S antibody as a strong risk factor for DVT in non-SLE patients. Nojima, J., Kuratsune, H., Suehisa, E., Kawasaki, T., Machii, T., Kitani, T., Iwatani, Y., Kanakura, Y. Thromb. Haemost. (2002)
- Association between the prevalence of antibodies to beta(2)-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications. Nojima, J., Kuratsune, H., Suehisa, E., Futsukaichi, Y., Yamanishi, H., Machii, T., Iwatani, Y., Kanakura, Y. Clin. Chem. (2001)
- Anti-prothrombin antibodies combined with lupus anti-coagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosus. Nojima, J., Kuratsune, H., Suehisa, E., Futsukaichi, Y., Yamanishi, H., Machii, T., Kitani, T., Iwatani, Y., Kanakura, Y. Br. J. Haematol. (2001)